LIONBIRD (VENTURES) LTD.
LIONBIRD (VENTURES) LTD. is a Seed, r-and-d and early-stage fund in the US, Europe and Israel writing $200K–$1.5M checks into AI, Enterprise, Healthcare, biomed and hardware-industrial.
- Stages
- Seed, r-and-d, early-stage
- Sectors
- AI, Enterprise, Healthcare, biomed, hardware-industrial
- Check size
- $200K–$1.5M
- Invests in
- US-wide, Europe, Israel
- Actively investing
- Yes
- Founded
- 2012
- Assets under management
- $175M
Thesis
LionBird is a venture capital firm founded in 2012, specializing in pre-scale digital health companies. They focus on mission-driven teams realigning the human-technology relationship in healthcare, particularly leveraging artificial intelligence to enhance patient care. Their investment thesis centers on the digital health sector, including enterprise software, biomed, and hardware/industrial applications supporting healthcare innovation. They target R&D, Seed, and early-stage companies globally, with a strong presence in North America, Europe, and Israel, operating from offices in Tel Aviv and Evanston, Illinois. LionBird provides pre-scale capital and value-add assistance, emphasizing founder-led decision-making and reserving follow-on funds. With $175 million in AUM, they are investing out of their third fund, LionBird III, dedicated to early-stage digital health.
Common questions
Does LIONBIRD (VENTURES) LTD. invest at the Seed stage?
Yes. LIONBIRD (VENTURES) LTD. lists Seed, r-and-d and early-stage among the stages it invests in.
What check size does LIONBIRD (VENTURES) LTD. write?
LIONBIRD (VENTURES) LTD. writes $200K–$1.5M checks.
Where does LIONBIRD (VENTURES) LTD. invest?
LIONBIRD (VENTURES) LTD. invests in the US, Europe and Israel.